Nicox Receives Confirmation of 5-year Patent Term Extension of U.S. Patent for Latanoprostene Bunod, Commercialized as VYZULTA®

January 31, 2024

← Back to blog page

Cookies

By continuing to use this website, you agree to our Cookie Policy.